Researchers investigating Chinese hamster ovary (CHO) cell production reported that acetate accumulation driven by pyruvate metabolism can drive late-stage culture acidification and bispecific antibody degradation. The study points to a specific upstream metabolic mechanism affecting downstream product stability during manufacturing. For biologics developers, acetate is a known stress metabolite in mammalian culture, but the paper’s emphasis on degradation timing and bispecific-specific vulnerability adds actionable guidance for process development and control strategies. It also reinforces the value of metabolic monitoring to prevent failures late in batch runs. The work frames acetate not just as a quality-of-life parameter for yields, but as a causal factor for product loss late in production.